We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




PET/MR Found Best Imaging Modality for Detecting Coronary Arterial Disease

By MedImaging International staff writers
Posted on 23 Jun 2014
Print article
The hybrid molecular imaging technique called positron emission tomography and magnetic resonance (PET/MR) imaging, which provides vital data about cardiac and arterial function, has been found to be an effective molecular imaging tool for detecting coronary artery disease (CAD), according to a recent study. 

The researchers presented their findings at the Society of Nuclear Medicine and Molecular Imaging’s 2014 annual meeting, held June 7-11, 2014, in St. Louis (MO, USA). Ischemic heart disease, a narrowing of the arteries supplying blood to the heart, is a leading cause of death worldwide. Individuals suspected of having CAD frequently undergo a stress test called myocardial perfusion imaging (MPI) to target areas of arterial ischemia and risk of myocardial infarction, or heart attack. Many patients undergo a molecular imaging scan called single photon emission computed tomography (SPECT); however, recently PET/MR has emerged as a potential alternative due to its superiority for imaging the structures of soft tissues and the physiologic function of the heart. This study revealed that PET/MR is consistently accurate using coronary angiography as the reference standard for detecting CAD. 

“By combining two advanced imaging modalities, PET and MR, cardiac PET/MR imaging allows a union of anatomic information with MR and functional information with PET for a comprehensive view of the of the heart,” said lead author Jeffrey M.C. Lau, MD, PhD, from Washington University in St. Louis (MO, USA). “This allows us to predict or rule out coronary artery disease with more certainty, and in some instances, it allows us to detect disease processes such as areas of hibernating heart muscle that would not have been detected using conventional stress testing methods like SPECT.” 

Moreover, cardiac perfusion PET/MR can be performed in a shorter timeframe than SPECT and is associated with a lower dose of radiation per procedure, and MR can be used to produce an almost cinematic, multiple-frame sequence of the motion in specific regions of the heart muscle, most notably the left ventricle, which pumps oxygenated blood back into the body through the aorta. PET imaging also provides quantitative data about blood flow in addition to the visual interpretation of disease. 

The study involved 10 patients with reversible ischemia as indicated by SPECT-MPI. Scientists administered a radionuclide PET imaging agent called N-13 ammonia in addition to an MR contrast agent called gadolinium and the pharmaceutical Regadenoson, which imitates the stress of exercise. Regadenoson was developed by Astellas Pharma, Inc. (Tokyo, Japan).

The researchers optimized the cardiac PET/MR imaging protocol to register areas of reduced perfusion of blood using MR with PET data regarding myocardial blood flow. The findings showed that PET/MR imaging was very accurate in diagnostic coronary artery diseases. In this small sample, PET/MR had 100% sensitivity, 80% specificity, and 100% negative predictive value (NPV). Those numbers compare favorably to SPECT in this study group. 

This study was conducted in conjunction with Siemens Medical Solutions (Erlangen, Germany).

Related Links:

Washington University in St. Louis
 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Computed Tomography (CT) Scanner
Aquilion Serve SP
New
Portable Radiology System
DRAGON ELITE & CLASSIC
New
Digital Radiography Generator
meX+20BT lite

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.